Crossmark

High PD-L1 expression is associated with unfavorable clinical features in myelodysplastic neoplasms

Crossref DOI link: https://doi.org/10.1016/j.htct.2023.05.002

Published Print: 2024-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sampaio, Leticia Rodrigues https://orcid.org/0000-0002-5784-3135
Viana, Mateus de Aguiar https://orcid.org/0000-0001-6286-2720
de Oliveira, Vanessa Silva https://orcid.org/0000-0002-5840-5524
Ferreira, Bruna Vitoriano https://orcid.org/0000-0003-1766-1545
Melo, Mayara Magna Lima https://orcid.org/0000-0002-2077-7701
de Oliveira, Roberta Taiane Germano https://orcid.org/0000-0001-7782-3812
Borges, Daniela de Paula https://orcid.org/0000-0002-8254-5420
Magalhãesa, Silvia Maria Meira https://orcid.org/0000-0001-9638-6187
Pinheiro, Ronald F. https://orcid.org/0000-0003-3546-0974
Funding

Funding for this research was provided by:

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico (420501/2018-5, 424542/2016-1)

Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
License Information

Text and Data Mining valid from 2024-04-01

Text and Data Mining valid from 2024-04-01

Version of Record valid from 2023-05-30
More Information

This article is maintained by: Elsevier

Article Title: High PD-L1 expression is associated with unfavorable clinical features in myelodysplastic neoplasms

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2023.05.002

Content Type: article

Copyright: © 2023 Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.

Document is current

Any future updates will be listed below